Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) - No Study Results Posted

Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) (ACE)

This study is ongoing, but not recruiting participants.

Study NCT00989261 Information provided by Ambit Biosciences Corporation

First Received: October 1, 2009 Last Updated: November 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2012
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)